Electromyography Devices Market Expected to Reach $1.7 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Electromyography Devices Market," The electromyography devices market size was valued at $786.0 million in 2021, and is estimated to reach $1,648.7 billion by 2031, growing at a CAGR of 7.9% from 2022 to 2031. Electromyography (EMG) determines electrical activity or muscle response by responding to muscle stimulation. Neuromuscular abnormalities can be detected using EMG which assists in the diagnostic process. During testing, one or more small electrodes are inserted through the skin into the muscles. The electrical activity captured by the electrodes is also reflected in a monitor that shows the same electrical activity in the form of waves. A sound amplifier is used to hear the work.

There are two types of electromyography devices, including stationary electromyography systems, and portable electromyography systems that are used in the diagnostic procedure of muscle response. The electromyography device is used for detecting muscular disorders, and neuromuscular disorders, and in the study of nerve conduction, and evoked potential. Compliance with good manufacturing practices (GMP) is facilitated. The availability and development of new electromyography devices and better technology contribute toward the launch of improved products.

Growth of the electromyography devices market share is majorly driven by a surge in the geriatric population that is more vulnerable to neurological and muscular diseases, advancements of biofeedback equipment, rise in the prevalence of muscular disorders such as Alzheimer’s disease, Parkinson’s disease, migraine and Huntington's disease.

For instance, according to the World Health Organization in 2021, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. In 2050, 80% of older people will be living in low- and middle-income countries. According to Alzheimer’s Society, it is estimated that about 5.8 million people in the U.S. aged 65 years and above were affected by Alzheimer’s dementia in 2020. Hence, such factors propel the growth of the EMG devices market.

By product type, the stationary EMG systems segment is expected to witness the highest CAGR during the forecast period, owing to an increase in the prevalence of neuromuscular diseases, high adoption of stationary EMG systems for the diagnosis of neurovascular diseases, and an increase in technological advancements in stationary EMG systems.

On the basis of study type, the nerve conduction segment is expected to witness the highest CAGR during the forecast period, owing to an increase in investment in research studies, and an increase in the use of nerve conduction studies. Growth of the nerve conduction segment is also associated with an increase in cases of sciatic nerve problems, and chronic inflammatory polyneuropathy, which leads to an increase in the use of nerve conduction study for diagnosis it and boost the growth of the nerve conduction segment

On the basis of end-user, the clinic's segment is expected to witness the highest CAGR during the forecast period, owing to an increase in discounted rates for patients, an increase in the geriatric population that are more prone to neuromuscular disease, and an increase in a number of Alzheimer and Parkinson diseases and increase in a number of patients visits in clinics. The rise in healthcare expenditure also boosts the growth of the clinic's segment in the electromyography devices market.

Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to a surge in geriatric populations that are more prone to neuromuscular diseases, a rise in awareness regarding the use of portable electromyography devices for diagnosis of neuromuscular diseases, unmet medical demands, and increase in public-private investments in the healthcare sector.

KEY FINDINGS OF THE STUDY

• On the basis of product, the stationary EMG systems segment held the largest share of the electromyography devices market in 2021.
• By study type, the nerve conduction segment held the largest share of the electromyography devices market in 2021.
• The report includes an analysis of the regional as well as global Electromyography Devices Market Trends, key players, market segments, application areas, and Electromyography Devices Market Growth strategies.
• On the basis of end-user, the hospital's segment held the largest market share in 2021 in the Electromyography Devices Industry.
• On the basis of region, North America held the largest market share in 2021.